{"transactions":[{"id":2784077,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141231,"kind":"organization","name":"Point72 Biotech Private Investments, LLC","position":1,"cik":"0001850122","reported_name":"Point72 Biotech Private Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":141232,"kind":"organization","name":"Differentiated Ventures Investments, LLC","position":2,"cik":"0001850121","reported_name":"Differentiated Ventures Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":105233,"kind":"organization","name":"72 Investment Holdings, LLC","position":3,"cik":"0001832749","reported_name":"72 Investment Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":116948,"kind":"organization","name":"COHEN STEVEN A/SAC CAPITAL MGMT LP","position":4,"cik":"0000905226","reported_name":"COHEN STEVEN A/SAC CAPITAL MGMT LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series D-2 Preferred Stock","published_at":"2021-03-17T19:47:15.000Z","date":"2021-03-16","kind":"exercise","acquired":false,"shares":10846968,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The shares of the Issuer's Series D-2 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares of the Issuer's Series D-2 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the Issuer's Series D-2 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares of the Issuer's Series D-2 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Consist of shares of Series D-2 Preferred Stock held directly by Point72 Biotech."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein may be deemed to be beneficially owned by each: (i) Differentiated Ventures Investments, LLC (DVI), which is deemed the beneficial owner of shares held by Point72 Biotech Private Investments, LLC (Point72 Biotech), (ii) 72 Investment Holdings, LLC (72 IH), the sole member of DVI, deemed to have sole voting and investment control over such interest held by DVI, and (iii) Steven A. Cohen (SC), the sole member of 72 IH, deemed to have sole voting and investment control over such interest held by 72 IH. Each of SC, 72 IH, and DVI disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1084697},"source":{"system":"sec-edgar","filing":"0001209191-21-021571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/905226/000120919121021571/doc4.xml","form_type":"4"}},{"id":2784076,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141231,"kind":"organization","name":"Point72 Biotech Private Investments, LLC","position":1,"cik":"0001850122","reported_name":"Point72 Biotech Private Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":141232,"kind":"organization","name":"Differentiated Ventures Investments, LLC","position":2,"cik":"0001850121","reported_name":"Differentiated Ventures Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":105233,"kind":"organization","name":"72 Investment Holdings, LLC","position":3,"cik":"0001832749","reported_name":"72 Investment Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":116948,"kind":"organization","name":"COHEN STEVEN A/SAC CAPITAL MGMT LP","position":4,"cik":"0000905226","reported_name":"COHEN STEVEN A/SAC CAPITAL MGMT LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series D-1 Preferred Stock","published_at":"2021-03-17T19:47:15.000Z","date":"2021-03-16","kind":"exercise","acquired":false,"shares":7633277,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of the Issuer's Series D-1 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series D-1 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Series D-1 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of the Issuer's Series D-1 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Consist of shares of Series D-1 Preferred Stock held directly by Point72 Biotech."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein may be deemed to be beneficially owned by each: (i) Differentiated Ventures Investments, LLC (DVI), which is deemed the beneficial owner of shares held by Point72 Biotech Private Investments, LLC (Point72 Biotech), (ii) 72 Investment Holdings, LLC (72 IH), the sole member of DVI, deemed to have sole voting and investment control over such interest held by DVI, and (iii) Steven A. Cohen (SC), the sole member of 72 IH, deemed to have sole voting and investment control over such interest held by 72 IH. Each of SC, 72 IH, and DVI disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":763327},"source":{"system":"sec-edgar","filing":"0001209191-21-021571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/905226/000120919121021571/doc4.xml","form_type":"4"}},{"id":2784075,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141231,"kind":"organization","name":"Point72 Biotech Private Investments, LLC","position":1,"cik":"0001850122","reported_name":"Point72 Biotech Private Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":141232,"kind":"organization","name":"Differentiated Ventures Investments, LLC","position":2,"cik":"0001850121","reported_name":"Differentiated Ventures Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":105233,"kind":"organization","name":"72 Investment Holdings, LLC","position":3,"cik":"0001832749","reported_name":"72 Investment Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":116948,"kind":"organization","name":"COHEN STEVEN A/SAC CAPITAL MGMT LP","position":4,"cik":"0000905226","reported_name":"COHEN STEVEN A/SAC CAPITAL MGMT LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-03-17T19:47:15.000Z","date":"2021-03-16","kind":"purchase","acquired":true,"shares":800000,"price":19,"value":15200000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Point72 Associates, LLC (the Fund) is the direct owner of 800,000 shares of Common Stock. SC may be deemed to have an indirect pecuniary interest in such shares of Common Stock as an indirect holder of interests in the Fund."}],"balance_after":2648024,"source":{"system":"sec-edgar","filing":"0001209191-21-021571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/905226/000120919121021571/doc4.xml","form_type":"4"}},{"id":2784074,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141231,"kind":"organization","name":"Point72 Biotech Private Investments, LLC","position":1,"cik":"0001850122","reported_name":"Point72 Biotech Private Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":141232,"kind":"organization","name":"Differentiated Ventures Investments, LLC","position":2,"cik":"0001850121","reported_name":"Differentiated Ventures Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":105233,"kind":"organization","name":"72 Investment Holdings, LLC","position":3,"cik":"0001832749","reported_name":"72 Investment Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":116948,"kind":"organization","name":"COHEN STEVEN A/SAC CAPITAL MGMT LP","position":4,"cik":"0000905226","reported_name":"COHEN STEVEN A/SAC CAPITAL MGMT LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-03-17T19:47:15.000Z","date":"2021-03-16","kind":"exercise","acquired":true,"shares":1084697,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares of the Issuer's Series D-2 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein may be deemed to be beneficially owned by each: (i) Differentiated Ventures Investments, LLC (DVI), which is deemed the beneficial owner of shares held by Point72 Biotech Private Investments, LLC (Point72 Biotech), (ii) 72 Investment Holdings, LLC (72 IH), the sole member of DVI, deemed to have sole voting and investment control over such interest held by DVI, and (iii) Steven A. Cohen (SC), the sole member of 72 IH, deemed to have sole voting and investment control over such interest held by 72 IH. Each of SC, 72 IH, and DVI disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":1848024,"source":{"system":"sec-edgar","filing":"0001209191-21-021571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/905226/000120919121021571/doc4.xml","form_type":"4"}},{"id":2784073,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141231,"kind":"organization","name":"Point72 Biotech Private Investments, LLC","position":1,"cik":"0001850122","reported_name":"Point72 Biotech Private Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":141232,"kind":"organization","name":"Differentiated Ventures Investments, LLC","position":2,"cik":"0001850121","reported_name":"Differentiated Ventures Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":105233,"kind":"organization","name":"72 Investment Holdings, LLC","position":3,"cik":"0001832749","reported_name":"72 Investment Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":116948,"kind":"organization","name":"COHEN STEVEN A/SAC CAPITAL MGMT LP","position":4,"cik":"0000905226","reported_name":"COHEN STEVEN A/SAC CAPITAL MGMT LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-03-17T19:47:15.000Z","date":"2021-03-16","kind":"exercise","acquired":true,"shares":763327,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series D-1 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein may be deemed to be beneficially owned by each: (i) Differentiated Ventures Investments, LLC (DVI), which is deemed the beneficial owner of shares held by Point72 Biotech Private Investments, LLC (Point72 Biotech), (ii) 72 Investment Holdings, LLC (72 IH), the sole member of DVI, deemed to have sole voting and investment control over such interest held by DVI, and (iii) Steven A. Cohen (SC), the sole member of 72 IH, deemed to have sole voting and investment control over such interest held by 72 IH. Each of SC, 72 IH, and DVI disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":763327,"source":{"system":"sec-edgar","filing":"0001209191-21-021571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/905226/000120919121021571/doc4.xml","form_type":"4"}}]}